These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3274376

  • 1. Frequency of diabetes-related complications in renal allograft recipients prospectively randomized to cyclosporine or azathioprine.
    Pescovitz MD, Gruber SA, Ascher NL, Kruse LV, Najarian JS, Payne WD, Simmons RL, Sutherland DE, Fryd DS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1537-8. PubMed ID: 3274376
    [No Abstract] [Full Text] [Related]

  • 2. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS.
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose cyclosporine or azathioprine one year after renal transplantation.
    Forwell MA, Bradley JA, Briggs JD, Brown MW, Junor BJ, Macpherson SG, Watson MA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
    [No Abstract] [Full Text] [Related]

  • 4. Renal transplantation in diabetic patients: a survey of 100 cases.
    Fonseca JA, Ianhez LE, Sabbaga E, Arap S.
    Transplant Proc; 1992 Oct; 24(5):1777-9. PubMed ID: 1412839
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
    Henny FC, Kootte AM, van Bockel JH, Baldwin WM, Hermans J, Bos B, van Es LA, Paul LC.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
    [No Abstract] [Full Text] [Related]

  • 7. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL, Egidi MF, Naji A, Friedman AL, Holland MT, Tomaszewski JE, Samini F, Perloff J, Grossman R, Barker CF.
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quality of life on cyclosporine versus conventional therapy.
    Simmons RG, Abress LK.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
    [No Abstract] [Full Text] [Related]

  • 10. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
    Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS.
    Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
    [Abstract] [Full Text] [Related]

  • 11. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
    Santelli G, Hiesse C, Schovaert D, Fassi-Fihri S, Lantz O, Bensadoun H, Benoit G, Charpentier B, Martin E, Fries D.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine versus azathioprine in high risk cadaver kidney transplant recipients: a prospective randomized study.
    Norman DJ, Wetzsteon P, Barry JM, Bennett WM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1845. PubMed ID: 3079046
    [No Abstract] [Full Text] [Related]

  • 13. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W, Malaise J, Mark W, Koenigsrainer A, Margreiter R, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H, Lange H.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
    Serafinowicz A, Gaciong Z, Baçzkowska T, Durlik M, Lao M.
    Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
    [No Abstract] [Full Text] [Related]

  • 17. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
    Pomer S, Daniel V, Dreikorn K, Röhl L.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
    [No Abstract] [Full Text] [Related]

  • 18. A long-term prevention of diabetic nephropathy in a patient with type 1 diabetes after simultaneous pancreas and kidney transplantation.
    Nyumura I, Honda K, Babazono T, Taneda S, Horita S, Teraoka S, Yamaguchi Y, Iwamoto Y, Oda H.
    Clin Transplant; 2009 Aug; 23 Suppl 20():54-7. PubMed ID: 19594598
    [Abstract] [Full Text] [Related]

  • 19. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
    De Vecchi A, Tarantino A, Montagnino G, Egidi F, Vegeto A, Berardinelli L, Ponticelli C.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
    [No Abstract] [Full Text] [Related]

  • 20. Late complications in kidney-pancreas transplant recipients.
    Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Seaman DS, Huss E, Thistlethwaite JR.
    Transplant Proc; 1995 Dec; 27(6):3118. PubMed ID: 8539871
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.